Copertina

Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Qianyi Li, Chunxuan Wu, Shiqun Sun, Lingchao Yang, Yanyan Li, Yixin Niu, Li Zhang, Wei Li, Ying Yu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of Diabetes
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Healthy sleep score, acute myocardial infarction, and type 2 diabetes
di: Tomoyuki Kawada
Pubblicazione: (2024)

The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis
di: Gwyneth Kong, et al.
Pubblicazione: (2024)

Independent and interactive associations of heart rate and obesity with type 2 diabetes mellites: A population‐based study
di: Tianxin Zhu, et al.
Pubblicazione: (2024)

Effects of sodium‐glucose cotransporter‐2 inhibitors in myocardial infarction patients: A systematic review and meta‐analysis
di: Qiufeng Jia, et al.
Pubblicazione: (2024)

Construction and validation of nomogram prediction model for ketoacidosis in elderly diabetic patients based on baseline data and glycolipid metabolism
di: Aijin Niu, et al.
Pubblicazione: (2025)

Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study
di: Jaycie Koh, et al.
Pubblicazione: (2024)

Development of a diagnostic model of insulin‐related lipohypertrophy for patients with diabetes mellitus
di: Xiaohui Li, et al.
Pubblicazione: (2025)

The relationships between biological novel biomarkers Lp‐PLA2 and CTRP‐3 and CVD in patients with type 2 diabetes mellitus
di: Yanhong Chen, et al.
Pubblicazione: (2024)

Effectiveness of finerenone in Chinese patients with type 2 diabetes mellitus and chronic kidney disease with microalbuminuria: A retrospective real‐world study
di: Yiming Wu, et al.
Pubblicazione: (2025)

Effects of GLP ‐1 receptor agonists on incidence and outcomes of ischemic stroke and myocardial infarction: A systematic review and meta‐analysis
di: Nawal Alammari, et al.
Pubblicazione: (2025)

Proteomics‐enabled learning machine algorithms enhance the prediction of cardiovascular diseases in patients with type 2 diabetes mellitus
di: Bowei Yu, et al.
Pubblicazione: (2025)

High estradiol/testosterone ratio increased the risk of metabolic dysfunction‐associated steatotic liver disease in men with type 2 diabetes mellitus
di: Meng‐Han Li, et al.
Pubblicazione: (2025)

Association between serum β2‐microglobulin and left ventricular hypertrophy in patients with type 2 diabetes mellitus: A cross‐sectional study
di: Yuling Zhang, et al.
Pubblicazione: (2024)

TyG ‐ BMI index as a valuable risk of acute kidney injury in patients with heart failure: Insights from the MIMIC ‐ IV and eICU cohorts
di: Yiming Hua, et al.
Pubblicazione: (2025)

Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate‐protein kinase G signaling in diabetic mice
di: Shengping Lei, et al.
Pubblicazione: (2024)

Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
di: Xiaopeng Shao, et al.
Pubblicazione: (2024)

Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis
di: Khawaja M. Talha, et al.
Pubblicazione: (2024)

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes
di: Mohmmad Alghamdi, et al.
Pubblicazione: (2025)

A meta‐analysis of adverse offspring health outcomes in patients with gestational diabetes mellitus
di: Jiewen Guan, et al.
Pubblicazione: (2025)

Assessment of community‐managed blood glucose control in patients with diabetes mellitus in Shenzhen, China
di: Lihua Fang, et al.
Pubblicazione: (2024)

Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post‐hoc analysis of the EMMY trial
di: Caren Sourij, et al.
Pubblicazione: (2024)

Gastric filling ultrasound in assessing gastrointestinal motility in type 2 diabetic patients with neuropathy: A clinical study
di: Juan Yan, et al.
Pubblicazione: (2025)

Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large‐scale claim database analysis of Japan
di: Takeshi Horii, et al.
Pubblicazione: (2024)

Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus
di: Ching‐Kit Tsui, et al.
Pubblicazione: (2025)

Letter to the Editor in Response to “A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, high density lipoprotein, and glucose ( CHG ) index”
di: Ying Li, et al.
Pubblicazione: (2026)

Druggable targets and immunological mechanisms for type 1 diabetes treatment: Genetic evidence from multi‐omics Mendelian randomization combined with meta‐analysis
di: Xianghui Mei, et al.
Pubblicazione: (2025)

Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients
di: Yan Wang, et al.
Pubblicazione: (2024)

Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS
di: Fatema Said, et al.
Pubblicazione: (2024)

Mediating role of inflammatory biomarkers in the causal effect of body composition on glycaemic traits and type 2 diabetes
di: Liwan Fu, et al.
Pubblicazione: (2024)

Cost‐effectiveness of finerenone added to standard of care for patients with type 2 diabetes‐related chronic kidney disease in the United States
di: Cailin Zheng, et al.
Pubblicazione: (2024)

Care, control and complications of hospitalised patients with type 1 diabetes in China: A nationwide‐based registry study
di: Chao Deng, et al.
Pubblicazione: (2024)

Critical methodological concerns regarding the secondary analysis of a low‐carbohydrate diet trial on frailty in older diabetic patients
di: Li Zhou, et al.
Pubblicazione: (2025)

Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial
di: Paola Caruso, et al.
Pubblicazione: (2025)

Estimated glucose disposal rate predicts the risk of diabetic peripheral neuropathy in type 2 diabetes: A 5‐year follow‐up study
di: Yuanpin Zhang, et al.
Pubblicazione: (2024)

Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes
di: Yu‐Ting Yu, et al.
Pubblicazione: (2026)

Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
di: Rui Sun, et al.
Pubblicazione: (2025)

Associations of biochemical and metabolic markers with pregnancy outcomes in women with and without gestational diabetes mellitus: A prospective cohort study in eastern China
di: Xiuping Bian, et al.
Pubblicazione: (2026)

Relationship of the intensity of physical performance and sedentary time with uric acid in patients with type 2 diabetes
di: Jie Li, et al.
Pubblicazione: (2025)

Dapagliflozin and chiglitazar combination enhanced myocardial energy metabolism in high‐fat diet‐fed mice
di: Jieying Liu, et al.
Pubblicazione: (2025)

Optimisation of care among patients with diabetes mellitus and acute coronary syndrome through a specialised cardiodiabetes service—A registry study
di: Muhammad Usman Shah, et al.
Pubblicazione: (2025)